🔗 Permalink

Inventor profile of:

Raymond J. Andersen

City:

Vancouver

Country:

Canada

Published Applications:

Last publication date:

2021-12-16

Top Assignees for applications by Raymond J. Andersen

The entities that hold a legal rights for patent applications filed by inventor Andersen Raymond J.:

The University of British Columbia 9 Vancouver, Canada
British Columbia Cancer Agency Branch 6 Vancouver, Canada
The University of British Columbia 6 Vancouver, BC Canada
BRITISH COLUMBIA CANCER AGENCY BRANCH 4 Vancouver, BC Canada
Neurodyn, Inc. 2 Vancouver, British Columbia, Canada
PROVINCIAL HEALTH SERVICES AUTHORITY 2 Vancouver, Canada
NEURODYN, INC. 1 Vancouver, Canada
THE UNIVERSITY OF BRITISH COLUMBIA 1 Vancouver, British Columbia, Canada
Brittish Columbia Cancer Agency Branch 1 Vancouver, BC, Canada
The University of British Columbia 1 Vancouver, -

Recent patent applications by Andersen Raymond J.

Raymond J. Andersen from Vancouver, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-12-16

US20210387957A1

Chemistry; metallurgy

Bisphenol derivatives and their use as androgen receptor activity modulators

#2 | 2020-10-08

US20200317628A1

Chemistry; metallurgy

Bisphenol derivatives and their use as androgen receptor activity modulators

#3 | 2018-07-12

US20180193413A1

Human necessities

Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compositions thereof

#4 | 2017-10-05

US20170283377A1

Chemistry; metallurgy

Androgen receptor modulators and methods for their use

#5 | 2017-08-24

US20170239216A1

Human necessities

SMALL MOLECULE INHIBITORS OF N-TERMINUS ACTIVATION OF THE ANDROGEN RECEPTOR

#6 | 2016-03-10

US20160068466A1

Chemistry; metallurgy

ESTER DERIVATIVES OF ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE

#7 | 2015-12-03

US20150344424A1

Chemistry; metallurgy

Androgen receptor modulators and methods for their use

#8 | 2014-11-13

US20140335080A1

Chemistry; metallurgy

Ester derivatives of androgen receptor modulators and methods for their use

#9 | 2013-09-19

US20130245129A1

Chemistry; metallurgy

Diglycidic ether derivative therapeutics and methods for their use

#10 | 2013-05-23

US20130131167A1

Chemistry; metallurgy

Bisphenol derivatives and their use as androgen receptor activity modulators

#11 | 2013-05-02

US20130109758A1

Chemistry; metallurgy

BISPHENOL DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE

#12 | 2012-09-27

US20120244632A1

Human necessities

Sterol glucoside toxins

#13 | 2011-09-22

US20110230556A1

Chemistry; metallurgy

Diglycidic ether derivative therapeutics and methods for their use

#14 | 2011-09-22

US20110230539A1

Human necessities

Small molecule inhibitors of N-terminus activation of the androgen receptor

#15 | 2009-02-12

US20090042868A1

Chemistry; metallurgy

Indoleamine 2,3-dioxygenase (IDO) inhibitors

#16 | 2008-10-16

US20080255090A1

Chemistry; metallurgy

Ceratamines A and B, and Analogues, Syntheses and Pharmaceutical Compositions Thereof

#17 | 2006-11-09

US20060252705A1

Human necessities

Sterol glucoside toxins

#18 | 2006-06-27

US10481688

Antimitotic eleuthesides

InventorID:

224482 ⎘